Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Feb;83(2):623–628. doi: 10.1172/JCI113926

Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.

A S Hollister 1, R J Rodeheffer 1, F J White 1, J R Potts 1, T Imada 1, T Inagami 1
PMCID: PMC303723  PMID: 2521490

Abstract

We determined human and canine plasma clearance of atrial natriuretic factor (ANF) by lung, liver, and kidney from arteriovenous differences in plasma ANF and measured organ plasma flow. Human subjects had lower plasma ANF concentrations in the pulmonary vein or the pulmonary capillary wedge position when compared with the pulmonary artery, and both sites yielded pulmonary ANF extraction ratios of 24%. Canine lung ANF extraction was 19 +/- 3% and pulmonary ANF clearance was 328 +/- 78 ml/min per m2 vs. 357 +/- 53 ml/min per m2 in man. Hepatic plasma ANF clearance was 216 +/- 26 ml/min with an extraction ratio of 30 +/- 3% in humans and 199 +/- 89 ml/min and 36 +/- 6% in the dog. Renal plasma ANF clearance in human subjects was 78 +/- 12 ml/min per kidney and correlated well with each kidney's creatinine clearance (r = 0.58, P less than 0.05). The mean renal ANF extraction ratio was 35 +/- 4% in human subjects and 42 +/- 6% in the dog. These data quantitate the specific organ ANF clearances by lung, liver, and kidney in human subjects and in dogs and provide a rationale for elevated plasma ANF levels in cirrhosis, renal failure, and diseases accompanied by reduced perfusion of these organs. These findings support the conclusion that plasma ANF concentrations are dependent upon both the stimuli for ANF secretion as well as the specific organ clearances of ANF.

Full text

PDF
623

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. V., Raine A. E., Proudler A., Bloom S. R. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure. J Endocrinol. 1986 Aug;110(2):193–196. doi: 10.1677/joe.0.1100193. [DOI] [PubMed] [Google Scholar]
  2. Burnett J. C., Jr, Kao P. C., Hu D. C., Heser D. W., Heublein D., Granger J. P., Opgenorth T. J., Reeder G. S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986 Mar 7;231(4742):1145–1147. doi: 10.1126/science.2935937. [DOI] [PubMed] [Google Scholar]
  3. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gerbes A. L., Arendt R. M., Paumgartner G. Atrial natriuretic factor. Possible implications in liver disease. J Hepatol. 1987 Aug;5(1):123–132. doi: 10.1016/s0168-8278(87)80070-3. [DOI] [PubMed] [Google Scholar]
  5. Gerbes A. L., Arendt R. M., Ritter D., Jüngst D., Zähringer J., Paumgartner G. Plasma atrial natriuretic factor in patients with cirrhosis. N Engl J Med. 1985 Dec 19;313(25):1609–1610. doi: 10.1056/NEJM198512193132517. [DOI] [PubMed] [Google Scholar]
  6. Hasegawa K., Matsushita Y., Inoue T., Morii H., Ishibashi M., Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab. 1986 Oct;63(4):819–822. doi: 10.1210/jcem-63-4-819. [DOI] [PubMed] [Google Scholar]
  7. Kawasaki H., Uemasu J., Maeda N., Hirayama C., Kobayashi T., Sakurai H. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease. Am J Gastroenterol. 1987 Aug;82(8):727–731. [PubMed] [Google Scholar]
  8. Koehn J. A., Norman J. A., Jones B. N., LeSueur L., Sakane Y., Ghai R. D. Degradation of atrial natriuretic factor by kidney cortex membranes. Isolation and characterization of the primary proteolytic product. J Biol Chem. 1987 Aug 25;262(24):11623–11627. [PubMed] [Google Scholar]
  9. LEEVY C. M., MENDENHALL C. L., LESKO W., HOWARD M. M. Estimation of hepatic blood flow with indocyanine green. J Clin Invest. 1962 May;41:1169–1179. doi: 10.1172/JCI104570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morgan T. R., Imada T., Hollister A. S., Inagami T. Plasma human atrial natriuretic factor in cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1988 Dec;95(6):1641–1647. doi: 10.1016/s0016-5085(88)80090-8. [DOI] [PubMed] [Google Scholar]
  11. Olins G. M., Spear K. L., Siegel N. R., Zurcher-Neely H. A. Inactivation of atrial natriuretic factor by the renal brush border. Biochim Biophys Acta. 1987 Jul 10;901(1):97–100. doi: 10.1016/0005-2736(87)90260-4. [DOI] [PubMed] [Google Scholar]
  12. Raine A. E., Erne P., Bürgisser E., Müller F. B., Bolli P., Burkart F., Bühler F. R. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986 Aug 28;315(9):533–537. doi: 10.1056/NEJM198608283150901. [DOI] [PubMed] [Google Scholar]
  13. Rascher W., Tulassay T., Lang R. E. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet. 1985 Aug 10;2(8450):303–305. doi: 10.1016/s0140-6736(85)90351-4. [DOI] [PubMed] [Google Scholar]
  14. Richards A. M., Cleland J. G., Tonolo G., McIntyre G. D., Leckie B. J., Dargie H. J., Ball S. G., Robertson J. I. Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):409–412. doi: 10.1136/bmj.293.6544.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Riegger G. A., Kromer E. P., Kochsiek K. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure. J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1107–1112. [PubMed] [Google Scholar]
  16. Rodeheffer R. J., Tanaka I., Imada T., Hollister A. S., Robertson D., Inagami T. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. J Am Coll Cardiol. 1986 Jul;8(1):18–26. doi: 10.1016/s0735-1097(86)80086-9. [DOI] [PubMed] [Google Scholar]
  17. STAMEY T. A., NUDELMAN I. J., GOOD P. H., SCHWENTKER F. N., HENDRICKS F. Functional characteristics of renovascular hypertension. Medicine (Baltimore) 1961 Dec;40:347–394. doi: 10.1097/00005792-196112000-00002. [DOI] [PubMed] [Google Scholar]
  18. Sato F., Kamoi K., Wakiya Y., Ozawa T., Arai O., Ishibashi M., Yamaji T. Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. J Clin Endocrinol Metab. 1986 Oct;63(4):823–827. doi: 10.1210/jcem-63-4-823. [DOI] [PubMed] [Google Scholar]
  19. Schütten H. J., Henriksen J. H., Warberg J. Organ extraction of atrial natriuretic peptide (ANP) in man. Significance of sampling site. Clin Physiol. 1987 Apr;7(2):125–132. doi: 10.1111/j.1475-097x.1987.tb00154.x. [DOI] [PubMed] [Google Scholar]
  20. Shenker Y., Port F. K., Swartz R. D., Gross M. D., Grekin R. J. Atrial natriuretic hormone secretion in patients with renal failure. Life Sci. 1987 Sep 28;41(13):1635–1644. doi: 10.1016/0024-3205(87)90732-6. [DOI] [PubMed] [Google Scholar]
  21. Tang J., Webber R. J., Chang D., Chang J. K., Kiang J., Wei E. T. Depressor and natriuretic activities of several atrial peptides. Regul Pept. 1984 Sep;9(1-2):53–59. doi: 10.1016/0167-0115(84)90007-7. [DOI] [PubMed] [Google Scholar]
  22. Veress A. T., Chong C. K., Sonnenberg H. Inactivation of atrial natriuretic factor in blood. Can J Physiol Pharmacol. 1985 Dec;63(12):1615–1617. doi: 10.1139/y85-267. [DOI] [PubMed] [Google Scholar]
  23. Weselcouch E. O., Humphrey W. R., Aiken J. W. Effect of pulmonary and renal circulations on activity of atrial natriuretic factor. Am J Physiol. 1985 Nov;249(5 Pt 2):R595–R602. doi: 10.1152/ajpregu.1985.249.5.R595. [DOI] [PubMed] [Google Scholar]
  24. Zimmerman R. S., Schirger J. A., Edwards B. S., Schwab T. R., Heublein D. M., Burnett J. C., Jr Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog. Circ Res. 1987 Jul;61(1):63–69. doi: 10.1161/01.res.61.1.63. [DOI] [PubMed] [Google Scholar]
  25. von Schroeder H. P., Nishimura E., McIntosh C. H., Buchan A. M., Wilson N., Ledsome J. R. Autoradiographic localization of binding sites for atrial natriuretic factor. Can J Physiol Pharmacol. 1985 Nov;63(11):1373–1377. doi: 10.1139/y85-226. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES